Recurrent heart attacks and stroke, decreased by novel Nano therapy

30% of people who suffer a heart attack will do the same in the near future because cardiologists are unable to keep inflammation inside heart arteries under control. A report published in Nature Communications by Icahn School of Medicine at Mount Sinai focuses on a new technique which was recently developed and gives the solution to high risk of repeated heart attacks. We`re talking about the HDL (high-density lipoprotein which was tested by an international research team, led by Mount Sinai investigators. The senior investigator of the study is Willem Mulder, PhD, Associate Professor of Radiology in the Translational and Molecular Imaging Institute at the Icahn School of Medicine at Mount Sinai. According to the senior investigator, the HDL nanotherapy reduced both risks to repeated heart attacks and stroke. “While we have much more to do to confirm clinical benefit in patients, our study shows how this nanotherapy functions biologically, and how this novel concept could potentially also work in the clinical setting to solve a critical problem”, says Dr. Mulder.